HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ICI 174864, a putative delta opioid antagonist, reverses endotoxemic hypotension: pretreatment with dynorphin 1-13, A kappa agonist, blocks this action.

Abstract
The putative delta opioid receptor antagonist ICI 174864 (3 mg/kg, i.v.) significantly reversed endotoxic shock hypotension at a dose which lacked significant pressor actions in normotensive, non-endotoxemic rats. In contrast, dynorphin 1-13, when administered either before (0.1 or 1.0 mg/kg, i.v.) or following (1.0 mg/kg, i.v.) injection of endotoxin, failed to alter the course of ensuing circulatory shock. Additionally, pretreatment with dynorphin 1-13 prevented the subsequent reversal of endotoxemic hypotension by ICI 174864. It is concluded that: 1) delta opioid receptors mediate the endogenous opioid component of endotoxic shock hypotension; and 2) functional interactions occur between ligands for mu, delta, and kappa opioid receptor subtypes, which may predict potential interactions with a common macromolecular opioid receptor complex.
AuthorsJ B Long, B A Ruvio, C E Glatt, J W Holaday
JournalNeuropeptides (Neuropeptides) Vol. 5 Issue 1-3 Pg. 291-4 (Dec 1984) ISSN: 0143-4179 [Print] Netherlands
PMID6152327 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Peptide Fragments
  • Receptors, Opioid
  • Receptors, Opioid, delta
  • Receptors, Opioid, kappa
  • Enkephalin, Leucine
  • dynorphin (1-13)
  • Dynorphins
  • N,N-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine
Topics
  • Animals
  • Blood Pressure (drug effects)
  • Dynorphins (pharmacology)
  • Enkephalin, Leucine (analogs & derivatives, pharmacology)
  • Male
  • Peptide Fragments (pharmacology)
  • Rats
  • Rats, Inbred Strains
  • Receptors, Opioid (drug effects, physiology)
  • Receptors, Opioid, delta
  • Receptors, Opioid, kappa
  • Shock, Septic (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: